UNSPSC 51261705: Icatibant acetate
Commodity
Code facts
- Part of
-
-
51000000
-
51260000
- 51261700
-
51260000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51261705
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes an adrenergic beta-antagonist C59H89N19O13S.C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 325O8467XK, chemically known as l-arginine, d-arginyl-l-arginyl-l-prolyl-trans-4-hydroxy-l-prolylglycyl-3-(2-thienyl)-l-alanyl-l-seryl-d-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-l-(2.alpha.,3a.beta.,7a.beta.)-octahydro-1h-indole-2-carbonyl-, acetate (salt), but more generally known as icatibant acetate, which bears US NIH Compound Identifier 6918172.
Read the full definition
European Medicines Agency schedules Icatibant acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29718. Most nations, for tariff and trade purposes, schedule icatibant acetate under HS 29349990 and SITC 51579. As of Q4 2014, ICATIBANT ACETATE remains US FDA's Preferred Term for this commodity. Icatibant acetate bears US NLM identifiers UMLS ID C0082926 and NCI Concept Code C98884.
SMILES: CC(=O)O.C1CCC2C(C1)C[C@@H](N(C2)C(=O)[C@H](CO)NC(=O)[C@H](CC3CCCS3)NC(=O)CNC(=O)[C@@H]4C[C@H](CN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)N)O)C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)O.
About UNSPSC 51261705
UNSPSC 51261705 Icatibant acetate is a Commodity code for a specific pharmaceutical product, but the recent state and local opportunities posted under this code show a significant mismatch with the nominal scope. The Seminole County, Florida IFB60459723LAS procurement tags naloxone and drug deactivation systems—emergency opioid-reversal and controlled-substance disposal products—while the Texas Health and Human Services Commission RFI HHS0017013 solicits vendor capacity for direct-to-manufacturer prescription fulfillment and pharmacy benefit management. Neither opportunity involves icatibant acetate, a rare disease therapeutic used primarily in emergency treatment of hereditary angioedema. The code shows little relevant recent activity aligned with its stated pharmaceutical product line.
Seminole County issued IFB60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; response deadline was July 26, 2023. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026, soliciting vendor information on direct-to-manufacturer prescription contracting capabilities and direct relationships with self-insured health plans and state agencies. Activity under this code spans Florida and Texas, but the pharmaceutical products and services being actively procured do not correspond to icatibant acetate. Firms considering pursuit should verify whether state and local procurement offices are actually buying icatibant acetate or related rare-disease therapeutics before investing in capability development under this code.
Quick answers
What is UNSPSC 51261705?
UNSPSC 51261705 is Icatibant acetate, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51261705?
UNSPSC 51261705 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51261705
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code